Liver Neoplasms Clinical Trial
— RCTOfficial title:
The Role of Continuous Low Serratus Anterior Plane Block in Hepatocellular Carcinoma Surgery: a Randomised Clinical Trial.
To investigate the clinical application of ultrasound-guided continuous low serratus anterior plane block in open surgery for hepatocellular carcinoma.
Status | Recruiting |
Enrollment | 160 |
Est. completion date | February 29, 2024 |
Est. primary completion date | February 29, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: 1. Age 18-60 years; 2. ASAI-II; 3. BMI: 18-29 kg/m2 Exclusion Criteria: 1. Combined cardiac, cerebral, hepatic, and renal failure; 2. Comorbid psychiatric and neuromuscular disorders; 3. A history of allergy to anesthetic drugs; 4. Participation in other recent clinical or drug trials. |
Country | Name | City | State |
---|---|---|---|
China | The First People's Hospital of Neijiang | Neijiang | Sichuan |
Lead Sponsor | Collaborator |
---|---|
Liu Di |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Block plane | The effect of anesthesia after ultrasound-guided nerve block was measured using planimetry, as well as the area being anesthetized. The chest wall between T2-T9 and ice cotton balls was used to assess the extent and extent of anesthesia block. | 30 minute after the surgery begins | |
Primary | visual analogue scale | The visual analogue scale (VAS) of the patient's pain was recorded 24 hours after operation. | 24 hours after surgery | |
Primary | visual analogue scale | The visual analogue scale (VAS) of the patient's pain was recorded 48 hours after operation. | 48 hours after surgery. | |
Primary | visual analogue scale | The visual analogue scale (VAS) of the patient's pain was recorded 36 hours after operation. | 36 hours after surgery. | |
Secondary | Patient satisfaction | The patient's satisfaction with the analgesia 2 days after surgery was recorded. The analgesic effect: 1-3 as satisfactory, 4-6 as unsatisfactory, 7-10 as ineffective | 48 hours after surgery. | |
Secondary | Remedial analgesic drug | Whether other analgesic drugs were added within 24 hours after operation was recorded | 24 hours after surgery. | |
Secondary | Intraoperative blood pressure changes | Blood pressure changes were measured directly by radial artery puncture and recorded.
The changes in blood pressure and heart rate before and after excision and the use of intraoperative opioids. |
2 hours after the beginning of surgery. | |
Secondary | Intraoperative heart rate changes | The curve of the change of the operative heart rate was recorded through the anesthesia machine. | 2 hours after the beginning of surgery. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03651154 -
Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections
|
N/A | |
Not yet recruiting |
NCT03592550 -
The eValuation of Image Guidance of Stereotactic Body Radiotherapy Using Ultrasound: Assessment in Liver
|
||
Not yet recruiting |
NCT02521129 -
A New Track Ablation Device for Liver Biopsy: A Feasibility Study
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT02168608 -
Remote Ischemia Precondition (RIPC) for Hepatic Protection in Patients Undergoing Hepatectomy
|
N/A | |
Enrolling by invitation |
NCT01465425 -
Extracolonic Findings on Computed Tomography (CT) Colonography
|
||
Active, not recruiting |
NCT01177007 -
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
|
Phase 2 | |
Completed |
NCT00788697 -
SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization
|
Phase 3 | |
Recruiting |
NCT01564810 -
Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer
|
Phase 4 | |
Completed |
NCT00094003 -
Study of NS-9 in Patients With Liver Metastases
|
Phase 1 | |
Terminated |
NCT00051532 -
Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
|
N/A | |
Completed |
NCT00001587 -
A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver
|
Phase 1 | |
Completed |
NCT00222664 -
Qidong Hepatitis B Intervention Study
|
Phase 4 | |
Recruiting |
NCT04518852 -
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
|
Phase 2 | |
Completed |
NCT03289273 -
Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)
|
||
Terminated |
NCT03349255 -
Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma
|
Phase 1 | |
Recruiting |
NCT05068180 -
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients
|
Phase 4 | |
Recruiting |
NCT03715517 -
Spinal Anesthesia For Enhanced Recovery After Liver Surgery
|
N/A | |
Terminated |
NCT03685591 -
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
|
Phase 1 | |
Terminated |
NCT01744054 -
Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization
|
Phase 1 | |
Active, not recruiting |
NCT02969096 -
Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma
|
Phase 2 |